You are here

Corporate digest

Cordlife Group

CORDLIFE Group said on Tuesday that it has rejected an unsolicited third party offer for its shares in China Cord Blood Corporation and convertible notes due 2017. Instead, it will proceed with an earlier plan to sell them to Hang Seng-listed healthcare

sentifi.com

Market voices on:

Powered by GET.comGetCom